2023 Partners

ThermoFisher Scientific
Expertise Partner

Thermo Fisher Scientific is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them


Aldevron (002)

Expertise Partner

Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components in commercially available drugs and medical devices.  

Aldevron is known for inventing the GMP-Source® quality system and for specializing in cGMP manufacturing, operating the world’s largest facility at its company headquarters in Fargo, North Dakota, with additional facilities in Madison, Wisconsin.




Program Partner

CRISPR QC, a trailblazer in gene-editing analytics, merges Nobel Prize-winning technologies (graphene & CRISPR) to offer a pioneering Analytics Platform. Empowering researchers with real-time insights, we quantify risks, ensure consistency, and provide actionable data, shaping the future of gene editing and scientific innovation.


Basecamp Research 

Innovation Partner

Basecamp Research discovers & designs novel gene editing systems, including Cas enzymes and fusion proteins such as deaminases. We’ve built a comprehensive knowledge graph of global microbial diversity by partnering with local sampling teams who care for every type of environment on this planet, from glacial waters to volcanic soils. By combining our proprietary data with our AI platform, we can discover and design protein products that nobody else can.


Akron Biotech
Exhibition Partner

Akron Bio drives advanced therapy development and commercialization with high-quality, industrial-scale solutions. Akron’s strategic focus is supplying cGMP-compliant ancillary materials and services to enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, plasmid DNA manufacturing, and custom development services. As a regulatory-compliant company (ISO certified), Akron supports clients with rigorous documentation and quality standards to fulfill their regulatory demands. Our unique capabilities allow us to seamlessly transition from R&D to preclinical and clinical development with minimal change control and thus drive the emerging regenerative medicine sector to unmet clinical needs through affordable and seamless manufacturing options. 


Exhibition Partner

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.


Sumitomo Chemical

Sumitomo Chemical
Event Partner

Sumitomo Chemical is a leading provider of gRNA for therapeutic genome editing. At our brand-new, state-of-the-art cGMP facility in Japan, we deliver top-notch gRNA at unmatched purity levels - 100mer with 90% purity; 130mer with over 80% purity; 200mer and even longer gRNAs with world-class quality. Our standardized manufacturing method allows us to offer seamless scale up from lab to plant, at short lead time.